Enzon Pharmaceuticals Inc. (ENZN)
NASDAQ: Health Care
$6.50
0.18 | 2.85%
0.18 | 2.85%
Today's Range:
6.32 -
6.50
ENZN Avg. Daily Volume:
197,900
05/29/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.32 |
| 52 Week High | 10.79 |
| 52 Week Low | 5.79 |
| Avg. Daily Vol. (Mil) | 0.20 |
| Beta (3 year) | 1.16 |
| Share Related Items | |
| Mkt Cap (Mil) | 305.29 |
| Shares Out (Mil) | 48.31 |
| Float (Mil) | 27.60 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.60 |
| Current Ratio | 9.80 |
| LT Debt/ Equity | 0.64 |
| Total Debt / Equity | 0.64 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 7.51 |
| Price/Book | 1.55 |
| Price/Cash Flow | -18.20 |
| Per Share Data | |
| Earnings | -0.44 |
| Sales | 0.84 |
| Book Value | 4.08 |
| Cash Flow | -0.35 |
| Business Summary | |
|---|---|
| Enzon Pharmaceuticals, Inc. is engaged in developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions. | |
| General Information | |
| 20 Kingsbridge Road
Piscataway, NJ 08854 |
|
| www.enzon.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 72 | |
| CEO: Mr. George W. Hebard, II | |
| Short Interest | |
| Current Month (Mil) | 3.86 |
| Previous Month (Mil) | 4.18 |
| Short Interest Ratio (Days) | 24.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -6.60 |
| Return on Investments | -6.90 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -39.80 |
| Profit Margin | -54.80 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.79
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet